Lamsal Madhab, Gautam Narayan, Bhatta Narendra, Majhi Shankar, Baral Nirmal, Bhattacharya Shyamal Kumar
Department of Biochemistry, B.P. Koirala Institute of Health Sciences, Dharan, Nepal.
Southeast Asian J Trop Med Public Health. 2007 Mar;38(2):363-9.
Adenosine deaminase activity (ADA) was assayed in pleural fluid and serum of 42 subjects with pleural effusion. Twenty-nine of them had TB pleural effusion and the remaining 13 had pleural effusion due to non-TB respiratory diseases. Serum adenosine deaminase activity were also measured in 32 pulmonary tuberculosis patients without pleural effusion and equal numbers of healthy controls without systemic diseases for comparative analysis. The patients attending the medicine out-patient department (MOPD) of the B. P. Koirala Institute of Health Sciences, Dharan, Nepal were taken as study subjects. Serum and pleural fluid ADA activities were assayed spectrophotometrically by the method of Guisti and Gallanti. The mean serum ADA activity was significantly increased in patients with tubercular pleural effusion (34.53 +/- 10.27 IU/l) compared to pulmonary tuberculosis patients without pleural effusion (26.54 +/- 4.76 IU/l), (p = 0.004), those with non-TB respiratory disease (16.71 +/- 5.16 IU/l), (p = 0.0001) and healthy controls (15.53 +/- 4.4 IU/l) (p = 0.0001). The mean ADA in the pleural fluid of tubercular pleural effusion patients (90.29 +/- 54.80 IU/l) was significantly higher compared to those with non-TB respiratory disease (24.43 +/- 9.28 IU/l) (p = 0.0001). Using the lowest cutoff value for enzyme activity in the serum of patients with TB pleural effusion (25 IU/l), a test sensitivity of 72.41% and specificity of 81.53% were obtained. Using the lowest cutoff value for enzyme activity in pleural fluid of patients with TB pleural effusion (45 IU/l) the sensitivity and specificity for diagnosis were 76.10% and 100%, respectively. Therefore, the measurement of ADA in tubercular pleural effusion has a utility in the diagnosis of tuberculosis when other clinical and laboratory tests are negative.
对42例胸腔积液患者的胸腔积液和血清进行了腺苷脱氨酶活性(ADA)检测。其中29例为结核性胸腔积液,其余13例为非结核性呼吸系统疾病所致胸腔积液。还对32例无胸腔积液的肺结核患者和数量相等的无全身性疾病的健康对照者测定了血清腺苷脱氨酶活性,用于比较分析。以尼泊尔达兰市BP柯伊拉腊健康科学研究所内科门诊的患者作为研究对象。采用Giusti和Gallanti方法通过分光光度法测定血清和胸腔积液ADA活性。与无胸腔积液的肺结核患者(26.54±4.76 IU/l)相比,结核性胸腔积液患者的平均血清ADA活性显著升高(34.53±10.27 IU/l),(p = 0.004);与非结核性呼吸系统疾病患者(16.71±5.16 IU/l)相比,(p = 0.0001);与健康对照者(15.53±4.4 IU/l)相比,(p = 0.0001)。结核性胸腔积液患者胸腔积液中的平均ADA(90.29±54.80 IU/l)显著高于非结核性呼吸系统疾病患者(24.43±9.28 IU/l),(p = 0.0001)。采用结核性胸腔积液患者血清中酶活性的最低临界值(25 IU/l),检测敏感性为72.41%,特异性为81.53%。采用结核性胸腔积液患者胸腔积液中酶活性的最低临界值(45 IU/l),诊断敏感性和特异性分别为76.10%和100%。因此,当其他临床和实验室检查均为阴性时,测定结核性胸腔积液中的ADA对结核病的诊断具有实用价值。